Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Alzheimer's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 153 articles:
HTML format
Text format



Single Articles


    March 2010
  1. FELDMAN HH , Doody RS, Kivipelto M, Sparks DL, et al
    Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease. LEADe.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. ARVANITAKIS Z , Knopman DS
    Clinical trial efforts in Alzheimer disease. Why test statins?
    Neurology. 2010.
    PubMed     Text format     Related articles   


    February 2010
  3. SWERDLOW RH
    An Alzheimer disease presenilin mutation, syndrome diversity, and a shrinking world.
    Neurology. 2010.
    PubMed     Text format     Related articles   


  4. ZOU F , Carrasquillo MM, Pankratz VS, Belbin O, et al
    Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease.
    Neurology. 2010;74:480-6.
    PubMed     Text format     Related articles    Abstract available


  5. HORNBERGER M , Piguet O, Graham AJ, Nestor PJ, et al
    How preserved is episodic memory in behavioral variant frontotemporal dementia?
    Neurology. 2010;74:472-9.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  6. BRENNER SR , Roh JK, Lee ST, Chu K, et al
    Reduced circulating angiogenic cells in Alzheimer disease.
    Neurology. 2010;74:346.
    PubMed     Text format     Related articles   


  7. HONEA RA , Swerdlow RH, Vidoni ED, Goodwin J, et al
    Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.
    Neurology. 2010;74:113-20.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  8. PETERSEN RC , Aisen PS, Beckett LA, Donohue MC, et al
    Alzheimer's Disease Neuroimaging Initiative (ADNI). Clinical characterization.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  9. ROE CM , Fitzpatrick AL, Xiong C, Sieh W, et al
    Cancer linked to Alzheimer disease but not vascular dementia.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  10. BENNETT DA , Leurgans S
    Is there a link between cancer and Alzheimer disease?
    Neurology. 2009.
    PubMed     Text format     Related articles   


  11. CORDER EH , Caskey J
    Early intervention in Alzheimer disease. The importance of APOE4 plus family history.
    Neurology. 2009.
    PubMed     Text format     Related articles   


    November 2009
  12. SALLOWAY S , Sperling R, Gilman S, Fox NC, et al
    A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  13. KAUFER D , Gandy S
    APOE {epsilon}4 and bapineuzumab. Infusing pharmacogenomics into Alzheimer disease therapeutics.
    Neurology. 2009.
    PubMed     Text format     Related articles   


  14. GOLOB EJ , Ringman JM, Irimajiri R, Bright S, et al
    Cortical event-related potentials in preclinical familial Alzheimer disease.
    Neurology. 2009;73:1649-55.
    PubMed     Text format     Related articles    Abstract available


  15. CLIFFORD DB , Fagan AM, Holtzman DM, Morris JC, et al
    CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  16. FOTUHI M , Hachinski V, Kivipelto M, Whitehouse P, et al
    Factors associated with resistance to dementia despite high Alzheimer disease pathology.
    Neurology. 2009;73:1607.
    PubMed     Text format     Related articles   


  17. CRANE PK , Doody RS
    Donepezil treatment of patients with mci: a 48-week randomized, placebo- controlled trial.
    Neurology. 2009;73:1514-5.
    PubMed     Text format     Related articles   


    October 2009
  18. SANZ C , Andrieu S, Sinclair A, Hanaire H, et al
    Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Neurology. 2009;73:1359-66.
    PubMed     Text format     Related articles    Abstract available


  19. KESTER MI , van der Vlies AE, Blankenstein MA, Pijnenburg YA, et al
    CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Neurology. 2009;73:1353-8.
    PubMed     Text format     Related articles    Abstract available


  20. RAJI CA , Lopez OL, Kuller LH, Carmichael OT, et al
    Age, Alzheimer disease, and brain structure.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  21. HENNEMAN WJ , Vrenken H, Barnes J, Sluimer IC, et al
    Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.
    Neurology. 2009;73:935-40.
    PubMed     Text format     Related articles    Abstract available


  22. KILLIANY RJ
    Isn't amyloid more than just a marker for Alzheimer disease?
    Neurology. 2009.
    PubMed     Text format     Related articles   


  23. HOLMES C , Cunningham C, Zotova E, Woolford J, et al
    Systemic inflammation and disease progression in Alzheimer disease.
    Neurology. 2009;73:768-74.
    PubMed     Text format     Related articles    Abstract available


  24. PILOTTO A , Franceschi M, D'Onofrio G, Bizzarro A, et al
    Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.
    Neurology. 2009;73:761-7.
    PubMed     Text format     Related articles    Abstract available


  25. SCHEININ NM , Aalto S, Koikkalainen J, Lotjonen J, et al
    Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  26. TSAI PH , Mendez MF
    Akinetopsia in the posterior cortical variant of Alzheimer disease.
    Neurology. 2009;73:731-2.
    PubMed     Text format     Related articles   


  27. VAN VLIET P , Westendorp RG, Eikelenboom P, Comijs HC, et al
    Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.
    Neurology. 2009;73:681-7.
    PubMed     Text format     Related articles    Abstract available


  28. DESCHAINTRE Y , Richard F, Leys D, Pasquier F, et al
    Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
    Neurology. 2009;73:674-80.
    PubMed     Text format     Related articles    Abstract available


  29. IACONO D , Markesbery WR, Gross M, Pletnikova O, et al
    The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.
    Neurology. 2009;73:665-73.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  30. SEIDENBERG M , Guidotti L, Nielson KA, Woodard JL, et al
    Semantic memory activation in individuals at risk for developing Alzheimer disease.
    Neurology. 2009;73:612-20.
    PubMed     Text format     Related articles    Abstract available


  31. NORTON JB , Cairns NJ, Chakraverty S, Wang J, et al
    Presenilin1 g217r mutation linked to Alzheimer disease with cotton wool plaques.
    Neurology. 2009;73:480-2.
    PubMed     Text format     Related articles   


  32. MCDONALD CR , McEvoy LK, Gharapetian L, Fennema-Notestine C, et al
    Regional rates of neocortical atrophy from normal aging to early Alzheimer disease.
    Neurology. 2009;73:457-65.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  33. LIPPA CF
    Compensating for Alzheimer lesions. Evidence that size counts.
    Neurology. 2009.
    PubMed     Text format     Related articles   


  34. VISSER PJ , Knopman DS
    Amyloid imaging in the prediction of Alzheimer-type dementia in subjects with amnestic MCI.
    Neurology. 2009.
    PubMed     Text format     Related articles   


  35. VEMURI P , Wiste HJ, Weigand SD, Shaw LM, et al
    MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
    Neurology. 2009;73:294-301.
    PubMed     Text format     Related articles    Abstract available


  36. VEMURI P , Wiste HJ, Weigand SD, Shaw LM, et al
    MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.
    Neurology. 2009;73:287-93.
    PubMed     Text format     Related articles    Abstract available


  37. FILLIT H , Hess G, Hill J, Bonnet P, et al
    IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.
    Neurology. 2009;73:180-5.
    PubMed     Text format     Related articles    Abstract available


  38. VERNOOIJ MW , Ikram MA, Hofman A, Krestin GP, et al
    Superficial siderosis in the general population.
    Neurology. 2009;73:202-5.
    PubMed     Text format     Related articles    Abstract available


  39. OKELLO A , Koivunen J, Edison P, Archer HA, et al
    Conversion of amyloid positive and negative MCI to AD over 3 years. An 11C-PIB PET study.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  40. LU PH , Edland SD, Teng E, Tingus K, et al
    Donepezil delays progression to AD in MCI subjects with depressive symptoms.
    Neurology. 2009;72:2115-21.
    PubMed     Text format     Related articles    Abstract available


  41. DRISCOLL I , Davatzikos C, An Y, Wu X, et al
    Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.
    Neurology. 2009;72:1906-13.
    PubMed     Text format     Related articles    Abstract available


  42. BREITNER JC , Haneuse SJ, Walker R, Dublin S, et al
    Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.
    Neurology. 2009;72:1899-905.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  43. LEE ST , Chu K, Jung KH, Park HK, et al
    Reduced circulating angiogenic cells in Alzheimer disease.
    Neurology. 2009;72:1858-63.
    PubMed     Text format     Related articles    Abstract available


  44. JESSEN F , Gur O, Block W, Ende G, et al
    A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Neurology. 2009;72:1735-40.
    PubMed     Text format     Related articles    Abstract available


  45. ONTANEDA D
    Race/ethnic differences in AD survival in us Alzheimer's disease centers.
    Neurology. 2009;72:1619.
    PubMed     Text format     Related articles   


  46. FONG TG , Jones RN, Shi P, Marcantonio ER, et al
    Delirium accelerates cognitive decline in Alzheimer disease.
    Neurology. 2009;72:1570-5.
    PubMed     Text format     Related articles    Abstract available


  47. KNOPMAN DS
    Cracking the therapeutic nut in mild cognitive impairment: better nuts and better nutcrackers.
    Neurology. 2009;72:1542-3.
    PubMed     Text format     Related articles   


    April 2009
  48. FRISONI GB , Lorenzi M, Caroli A, Kemppainen N, et al
    In vivo mapping of amyloid toxicity in Alzheimer disease.
    Neurology. 2009;72:1504-11.
    PubMed     Text format     Related articles    Abstract available


  49. BENNETT DA , De Jager PL, Leurgans SE, Schneider JA, et al
    Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.
    Neurology. 2009;72:1495-503.
    PubMed     Text format     Related articles    Abstract available


  50. BENNETT DA , Whitmer RA
    NSAID exposure and risk of Alzheimer disease. Is timing everything?
    Neurology. 2009.
    PubMed     Text format     Related articles   


  51. KIMBERLY WT , Gilson A, Rost NS, Rosand J, et al
    Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.
    Neurology. 2009;72:1230-5.
    PubMed     Text format     Related articles    Abstract available


  52. DRZEZGA A , Grimmer T, Henriksen G, Muhlau M, et al
    Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  53. PAULSEN JS , Duff K
    Extending MCI beyond Alzheimer disease.
    Neurology. 2009;72:1116-7.
    PubMed     Text format     Related articles   


  54. MANDEL S , Maitz EA
    A longitudinal study of drivers with Alzheimer disease.
    Neurology. 2009;72:1109.
    PubMed     Text format     Related articles   


  55. VAN DER VLIES AE , Verwey NA, Bouwman FH, Blankenstein MA, et al
    CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    Neurology. 2009;72:1056-61.
    PubMed     Text format     Related articles    Abstract available


  56. BAKKOUR A , Morris JC, Dickerson BC
    The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
    Neurology. 2009;72:1048-55.
    PubMed     Text format     Related articles    Abstract available


  57. ROTTENBERG DA
    Thin skin: the cortical signature of prodromal AD?
    Neurology. 2009;72:1038-9.
    PubMed     Text format     Related articles   


  58. HENNEMAN WJ , Sluimer JD, Barnes J, van der Flier WM, et al
    Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.
    Neurology. 2009;72:999-1007.
    PubMed     Text format     Related articles    Abstract available


  59. TEZAPSIDIS N , Smith MA, Ashford JW
    Central obesity and increased risk of dementia more than three decades later.
    Neurology. 2009;72:1030-1.
    PubMed     Text format     Related articles   


  60. CEREDA E , Sacchi MC, Malavazos AE
    Central obesity and increased risk of dementia more than three decades later.
    Neurology. 2009;72:1030-1.
    PubMed     Text format     Related articles   


  61. BERLAU DJ , Corrada MM, Head E, Kawas CH, et al
    APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old.
    Neurology. 2009;72:829-34.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  62. HOFFMAN LB , Schmeidler J, Lesser GT, Beeri MS, et al
    Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  63. HAAG MD , Hofman A, Koudstaal PJ, Breteler MM, et al
    Duration of antihypertensive drug use and risk of dementia. A prospective cohort study.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  64. KNOPMAN DS
    Hypertension and late-life dementia. A real link?
    Neurology. 2009.
    PubMed     Text format     Related articles   


  65. LANSKA DJ
    Race/ethnic differences in ad survival in us Alzheimer's disease centers.
    Neurology. 2009;72:678.
    PubMed     Text format     Related articles   


  66. REEVES S , Brown R, Howard R, Grasby P, et al
    Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease.
    Neurology. 2009;72:528-34.
    PubMed     Text format     Related articles    Abstract available


  67. DAWSON JD , Anderson SW, Uc EY, Dastrup E, et al
    Predictors of driving safety in early Alzheimer disease.
    Neurology. 2009;72:521-7.
    PubMed     Text format     Related articles    Abstract available


  68. DHAWAN V , Eidelberg D
    Mom and me: brain metabolism links Alzheimer disease to maternal genes.
    Neurology. 2009;72:486-7.
    PubMed     Text format     Related articles   


  69. WILSON RS , Hebert LE, Scherr PA, Barnes LL, et al
    Educational attainment and cognitive decline in old age.
    Neurology. 2009;72:460-5.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  70. DOODY RS , Ferris SH, Salloway S, Sun Y, et al
    Donepezil treatment of patients with MCI. A 48-week randomized, placebo-controlled trial.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  71. ERTEN-LYONS D , Woltjer RL, Dodge H, Nixon R, et al
    Factors associated with resistance to dementia despite high Alzheimer disease pathology.
    Neurology. 2009;72:354-60.
    PubMed     Text format     Related articles    Abstract available


  72. WELSH-BOHMER KA , White CL 3rd
    Alzheimer disease: what changes in the brain cause dementia?
    Neurology. 2009;72:e21.
    PubMed     Text format     Related articles   


  73. VISWANATHAN A , Rocca WA, Tzourio C
    Vascular risk factors and dementia: how to move forward?
    Neurology. 2009;72:368-74.
    PubMed     Text format     Related articles    Abstract available


  74. DHAMOON MS , Noble JM, Craft S
    Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Neurology. 2009;72:292-3.
    PubMed     Text format     Related articles   


  75. KIM SY , Kim HM, Langa KM, Karlawish JH, et al
    Surrogate consent for dementia research: a national survey of older Americans.
    Neurology. 2009;72:149-55.
    PubMed     Text format     Related articles    Abstract available


  76. SQUITTI R , Bressi F, Pasqualetti P, Bonomini C, et al
    Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
    Neurology. 2009;72:50-5.
    PubMed     Text format     Related articles    Abstract available


  77. OKELLO A , Edison P, Archer HA, Turkheimer FE, et al
    Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.
    Neurology. 2009;72:56-62.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  78. HUSSAIN HM , Zakria M, Arshad AR, Arvanitakis Z, et al
    Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
    Neurology. 2008;71:2019-20.
    PubMed     Text format     Related articles   


  79. DUARA R , Loewenstein DA, Potter E, Appel J, et al
    Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.
    Neurology. 2008;71:1986-92.
    PubMed     Text format     Related articles    Abstract available


  80. PAPPOLLA MA
    Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
    Neurology. 2008;71:2020.
    PubMed     Text format     Related articles   


    November 2008
  81. JOHNSON DK , Storandt M, Morris JC, Langford ZD, et al
    Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging.
    Neurology. 2008;71:1783-9.
    PubMed     Text format     Related articles    Abstract available


  82. KARCESKI S
    Patient page. Progressive supranuclear palsy.
    Neurology. 2008;71:e70-2.
    PubMed     Text format     Related articles   


  83. BORRONI B , Malinverno M, Gardoni F, Alberici A, et al
    Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Neurology. 2008;71:1796-803.
    PubMed     Text format     Related articles    Abstract available


  84. SEVIGNY JJ , Ryan JM, van Dyck CH, Peng Y, et al
    Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.
    Neurology. 2008;71:1702-8.
    PubMed     Text format     Related articles    Abstract available


  85. MOSCONI L , Mistur R, Switalski R, Brys M, et al
    Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  86. HELZNER EP , Scarmeas N, Cosentino S, Tang MX, et al
    Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.
    Neurology. 2008;71:1489-95.
    PubMed     Text format     Related articles    Abstract available


  87. MERCY L , Hodges JR, Dawson K, Barker RA, et al
    Incidence of early-onset dementias in Cambridgeshire, United Kingdom.
    Neurology. 2008;71:1496-9.
    PubMed     Text format     Related articles    Abstract available


  88. OKONKWO OC , Griffith HR, Copeland JN, Belue K, et al
    Medical decision-making capacity in mild cognitive impairment: a 3-year longitudinal study.
    Neurology. 2008;71:1474-80.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  89. GARIBOTTO V , Borroni B, Kalbe E, Herholz K, et al
    Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence.
    Neurology. 2008;71:1342-9.
    PubMed     Text format     Related articles    Abstract available


  90. VAN DER ZEE J , Sleegers K, Van Broeckhoven C
    Invited article: the Alzheimer disease-frontotemporal lobar degeneration spectrum.
    Neurology. 2008;71:1191-7.
    PubMed     Text format     Related articles    Abstract available


  91. VAN NORDEN AG , Fick WF, de Laat KF, van Uden IW, et al
    Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.
    Neurology. 2008;71:1152-9.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  92. SUNDELOF J , Arnlov J, Ingelsson E, Sundstrom J, et al
    Serum cystatin C and the risk of Alzheimer disease in elderly men.
    Neurology. 2008;71:1072-9.
    PubMed     Text format     Related articles    Abstract available


  93. CUSHMAN LA , Stein K, Duffy CJ
    Detecting navigational deficits in cognitive aging and Alzheimer disease using virtual reality.
    Neurology. 2008;71:888-95.
    PubMed     Text format     Related articles    Abstract available


  94. WILSON RS
    Advancing age, impending death, and declining cognition.
    Neurology. 2008;71:874-5.
    PubMed     Text format     Related articles   


  95. DJUPESLAND PG
    Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Neurology. 2008;71:864.
    PubMed     Text format     Related articles   


  96. BEERI MS , Schmeidler J, Silverman JM, Gandy S, et al
    Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology.
    Neurology. 2008;71:750-7.
    PubMed     Text format     Related articles    Abstract available


  97. WHITWELL JL , Josephs KA, Murray ME, Kantarci K, et al
    MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.
    Neurology. 2008;71:743-9.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  98. GRUNDMAN M , Gilman S, Black RS, Fox NC, et al
    An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease.
    Neurology. 2008;71:697.
    PubMed     Text format     Related articles   


  99. BENARROCH EE
    Suprachiasmatic nucleus and melatonin: reciprocal interactions and clinical correlations.
    Neurology. 2008;71:594-8.
    PubMed     Text format     Related articles   


  100. BUCHMAN AS , Schneider JA, Leurgans S, Bennett DA, et al
    Physical frailty in older persons is associated with Alzheimer disease pathology.
    Neurology. 2008;71:499-504.
    PubMed     Text format     Related articles    Abstract available


    July 2008
  101. DESIKAN RS , Fischl B, Cabral HJ, Kemper TL, et al
    MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  102. SIEGEL GJ , Chauhan NB, Feinstein DL, Li G, et al
    Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Neurology. 2008;71:383.
    PubMed     Text format     Related articles   


  103. BURNS JM , Cronk BB, Anderson HS, Donnelly JE, et al
    Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.
    Neurology. 2008;71:210-6.
    PubMed     Text format     Related articles    Abstract available


  104. SILVERBERG GD , Mayo M, Saul T, Fellmann J, et al
    Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study.
    Neurology. 2008;71:202-9.
    PubMed     Text format     Related articles    Abstract available


  105. QUINN J , Sabbagh MN
    Detecting Alzheimer disease before it happens: The key to prevention?
    Neurology. 2008;71:78-9.
    PubMed     Text format     Related articles   


    June 2008
  106. MCGURN B , Deary IJ, Starr JM
    Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  107. BROUWERS N , Sleegers K, Engelborghs S, Maurer-Stroh S, et al
    Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  108. GOLOMB BA , Evans MA
    Re: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Neurology. 2008;70:2349.
    PubMed     Text format     Related articles   


  109. FERRUCCI R , Mameli F, Guidi I, Mrakic-Sposta S, et al
    Transcranial direct current stimulation improves recognition memory in Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  110. FRISONI GB , Whitwell JL
    How fast will it go, doc? New tools for an old question from patients with Alzheimer disease.
    Neurology. 2008;70:2194-5.
    PubMed     Text format     Related articles   


  111. ARVANITAKIS Z , Grodstein F, Bienias JL, Schneider JA, et al
    Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
    Neurology. 2008;70:2219-25.
    PubMed     Text format     Related articles    Abstract available


    May 2008
  112. RINGMAN JM , Younkin SG, Pratico D, Seltzer W, et al
    Biochemical markers in persons with preclinical familial Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  113. SZEKELY CA , Green RC, Breitner JC, Ostbye T, et al
    No advantage of A{beta}42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  114. AISEN PS
    Treatment for MCI: is the evidence sufficient?
    Neurology. 2008;70:2020-1.
    PubMed     Text format     Related articles   


  115. WINBLAD B , Gauthier S, Scinto L, Feldman H, et al
    Safety and efficacy of galantamine in subjects with mild cognitive impairment.
    Neurology. 2008;70:2024-35.
    PubMed     Text format     Related articles    Abstract available


  116. YASSA MA , Verduzco G, Cristinzio C, Bassett SS, et al
    Altered fMRI activation during mental rotation in those at genetic risk for Alzheimer disease.
    Neurology. 2008;70:1898-904.
    PubMed     Text format     Related articles    Abstract available


  117. VLAD SC , Miller DR, Kowall NW, Felson DT, et al
    Protective effects of NSAIDs on the development of Alzheimer disease.
    Neurology. 2008;70:1672-7.
    PubMed     Text format     Related articles    Abstract available


  118. SLUIMER JD , Vrenken H, Blankenstein MA, Fox NC, et al
    Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  119. MUELLER SG , Dickerson BC
    Atrophy accelerates with conversion from mild cognitive impairment to Alzheimer disease.
    Neurology. 2008;70.
    PubMed     Text format     Related articles   


  120. DRACHMAN DA
    Nature or nurture: education and the trajectory of declining brain function with age and Alzheimer disease.
    Neurology. 2008;70.
    PubMed     Text format     Related articles   


  121. BIAN H , Van Swieten JC, Leight S, Massimo L, et al
    CSF biomarkers in frontotemporal lobar degeneration with known pathology.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  122. LOPEZ OL , Kuller LH, Mehta PD, Becker JT, et al
    Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study.
    Neurology. 2008;70:1664-71.
    PubMed     Text format     Related articles    Abstract available


  123. RAVAGLIA G , Forti P, Lucicesare A, Pisacane N, et al
    Physical activity and dementia risk in the elderly: findings from a prospective Italian study.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  124. JACK CR JR , Weigand SD, Shiung MM, Przybelski SA, et al
    Atrophy rates accelerate in amnestic mild cognitive impairment.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  125. KINKINGNEHUN S , Sarazin M, Lehericy S, Guichart-Gomez E, et al
    VBM anticipates the rate of progression of Alzheimer disease. A 3-year longitudinal study.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  126. LOVELL MA , Lynn BC, Xiong S, Quinn JF, et al
    An aberrant protein complex in CSF as a biomarker of Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  127. LINAZASORO G
    Imaging beta-amyloid burden in aging and dementia.
    Neurology. 2008;70:1649.
    PubMed     Text format     Related articles   


  128. POULOPOULOU C , Davaki P, Sgouropoulos P, Tsaltas E, et al
    Reduced rage mRNA in mononuclear blood cells of patients with probable Alzheimer disease.
    Neurology. 2008;70:1571-3.
    PubMed     Text format     Related articles   


  129. COSENTINO S , Scarmeas N, Helzner E, Glymour MM, et al
    APOE {epsilon}4 allele predicts faster cognitive decline in mild Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  130. RONNEMAA E , Zethelius B, Sundelof J, Sundstrom J, et al
    Impaired insulin secretion increases the risk of Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  131. JOSEPHS KA , Whitwell JL, Knopman DS, Hu WT, et al
    Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  132. GEERLINGS MI , den Heijer T, Koudstaal PJ, Hofman A, et al
    History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
    Neurology. 2008;70:1258-64.
    PubMed     Text format     Related articles    Abstract available


  133. TOBINICK EL
    Re: Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.
    Neurology. 2008;70:1222-3.
    PubMed     Text format     Related articles   


  134. FILLENBAUM GG
    Differential survival with Alzheimer disease.
    Neurology. 2008;70:1158-60.
    PubMed     Text format     Related articles   


  135. ERTEN-LYONS D
    When should patients with Alzheimer disease stop driving?
    Neurology. 2008;70:e45-47.
    PubMed     Text format     Related articles   


    March 2008
  136. ZACCAI J , Brayne C, McKeith I, Matthews F, et al
    Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Neurology. 2008;70:1042-8.
    PubMed     Text format     Related articles    Abstract available


  137. BOYLE PA , Wilson RS, Schneider JA, Bienias JL, et al
    Processing resources reduce the effect of Alzheimer pathology on other cognitive systems.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  138. WEINER MW
    Expanding ventricles may detect preclinical Alzheimer disease.
    Neurology. 2008;70:824-5.
    PubMed     Text format     Related articles   


  139. CARLSON NE , Moore MM, Dame A, Howieson D, et al
    Trajectories of brain loss in aging and the development of cognitive impairment.
    Neurology. 2008;70:828-33.
    PubMed     Text format     Related articles    Abstract available


  140. NANDIGAM RN
    Mixed brain pathologies account for most dementia cases in community-dwelling older persons.
    Neurology. 2008;70:816.
    PubMed     Text format     Related articles   


    February 2008
  141. ROZZINI L , Chilovi BV, Trabucchi M, Padovani A, et al
    Re: Predictors of progression from mild cognitive impairment to Alzheimer disease.
    Neurology. 2008;70:735.
    PubMed     Text format     Related articles   


  142. LARNER AJ , Hancock P
    Activities of daily living in frontotemporal dementia and Alzheimer disease.
    Neurology. 2008;70:658.
    PubMed     Text format     Related articles   


  143. CRYSTAL HA , Davies P
    Toward a plasma marker for Alzheimer disease: Some progress, but still a long way to go.
    Neurology. 2008;70:586-7.
    PubMed     Text format     Related articles   


  144. JAGUST W
    Is amnestic mild cognitive impairment always AD?
    Neurology. 2008;70:502-3.
    PubMed     Text format     Related articles   


  145. REGER MA , Watson GS, Green PS, Wilkinson CW, et al
    Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Neurology. 2008;70:440-8.
    PubMed     Text format     Related articles    Abstract available


    January 2008
  146. OTT BR , Heindel WC, Papandonatos GD, Festa EK, et al
    A longitudinal study of drivers with Alzheimer disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  147. RANSMAYR GN , Holliger S, Schletterer K, Heidler H, et al
    Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Neurology. 2008;70:299-303.
    PubMed     Text format     Related articles    Abstract available


  148. ARVANITAKIS Z , Schneider JA, Wilson RS, Bienias JL, et al
    Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  149. BRENNER SR
    Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
    Neurology. 2008;70:243-4.
    PubMed     Text format     Related articles   


  150. FLEISHER AS , Sun S, Taylor C, Ward CP, et al
    Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Neurology. 2008;70:191-9.
    PubMed     Text format     Related articles    Abstract available


  151. SZEKELY CA , Breitner JC, Fitzpatrick AL, Rea TD, et al
    NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type.
    Neurology. 2008;70:17-24.
    PubMed     Text format     Related articles    Abstract available


    December 2007
  152. EWERS M , Buerger K, Teipel SJ, Scheltens P, et al
    Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI.
    Neurology. 2007;69:2205-12.
    PubMed     Text format     Related articles    Abstract available


    September 2007
  153. WHITWELL JL , Shiung MM, Przybelski SA, Weigand SD, et al
    MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment.
    Neurology. 2007;.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: